Category: Medical

H1N1 Vaccine Safe in Pregnancy

July 10, 2012 — Exposure to adjuvanted influenza A(H1N1) vaccine before birth does not increase the risk for major birth defects, preterm birth, or fetal growth restriction, according to a study published in the July 10 issue of JAMA. Pregnant women face elevated risk for severe illness, death, and poor pregnancy outcome from influenza, and the…

Read More

Top Medical News Stories of 2011

1. FDA Calls for Simvastatin Limits The FDA played a role in most of this year’s top news stories, starting with a June 8 recommendation that physicians restrict prescribing high doses of the cholesterol medication simvastatin (Zocor, Merck) because of a risk for muscle damage. The FDA drug safety communication states that physicians should limit using the…

Read More

Metformin Curbs Ovarian Hyperstimulation in PCOS

Metformin cuts the risk of overstimulating the ovaries of women who have polycystic ovary syndrome (PCOS) and are receiving gonadotropin for in vitro fertilization, Italian researchers report in a paper online October 10 in Fertility and Sterility. Ovarian hyperstimulation syndrome, or OHSS, is a rare iatrogenic condition in which the ovaries grow and, in advanced…

Read More

Endometrial Ablation Has Advantages Over Hysterectomy for Heavy Menstruation

When women need treatment for heavy menstrual bleeding, endometrial ablation is less likely than hysterectomy to be followed later by pelvic floor repair or surgery for urinary incontinence, a Scottish study indicates. Using population-based data, Dr. S. Bhattacharya of the University of Aberdeen and colleagues examined the risk of further surgery in more than 51,000…

Read More

FDA Says Pharmacies Can Still Compound Generic Makena

Pharmacies can continue to compound generic hydroxyprogesterone caproate for reducing the risk for preterm delivery despite warnings from KV Pharmaceutical — which sells a costly, branded version of the drug — not to do so, the US Food and Drug Administration (FDA) announced today. On February 3, the FDA approved KV Pharmaceutical’s Makena, an injectable form of hydroxyprogesterone…

Read More

Cerclage Prevents Preterm Birth in At-Risk Pregnancies

NEW YORK (Reuters Health) – Among women with a singleton pregnancy, prior preterm birth, and a short cervix, cerclage significantly reduces the risk of another preterm delivery, as well as perinatal mortality and morbidity, a new meta-analysis shows. “The benefit of cerclage in this selected population is clear,” the research team says. “These results, consistent…

Read More

Top 10 Medical News Stories of 2010

Looking back, historians may mark 2010 as the most significant year for US medicine in decades. The healthcare reform legislation signed into law by President Barack Obama March 23 profoundly changes the way care is provided, and even if opponents succeed in repealing the legislation, the debate itself will shape the way we think about…

Read More
© 2019 Neera Bhatia MD OBGYN. All Rights Reserved. San Antonio Website Design & Development - Backyard Studios